NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

READYSTATE ASSET MANAGEMENT LP's Holding History (CIK: 0001900923)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 34,353 Value ($000) $977 Avg Close $23.97 Range $17.97 - $28.91

Q2 2025

Shares 231,194 Value ($000) $4,187 Avg Close $18.24 Range $14.06 - $22.25

Q1 2025

Shares 229,662 Value ($000) $4,701 Avg Close $22.23 Range $17.18 - $26.80

Q4 2024

Shares 260,400 Value ($000) $6,692 Avg Close $21.24 Range $15.51 - $27.29

Q3 2024

Shares 121,000 Value ($000) $2,009 Avg Close $17.30 Range $15.19 - $21.48

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	34,353	$977	$23.97	$17.97 - $28.91
Q2 2025	231,194	$4,187	$18.24	$14.06 - $22.25
Q1 2025	229,662	$4,701	$22.23	$17.18 - $26.80
Q4 2024	260,400	$6,692	$21.24	$15.51 - $27.29
Q3 2024	121,000	$2,009	$17.30	$15.19 - $21.48